BRVE Earnings Date: Dec 8, 2026 (Estimated) — Braveheart Bio, Inc.
NASDAQ
Updated
When is BRVE's next earnings date?
Braveheart Bio, Inc. (BRVE) is expected to report Q3 2026 earnings on Tuesday, December 8, 2026 at 1:56 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.97.
How did BRVE do in its last earnings report?
In its most recent report on Sep 8, 2026 (Q2 2026), Braveheart Bio, Inc. posted EPS of -$2.51 versus the $2.69 estimate, a miss of 439.2%. Revenue was $0. The stock's 1-day post-earnings move was -1.7%.
How much does BRVE stock move after earnings?
BRVE beat EPS estimates in 0 of its last 1 reported quarter.
About Braveheart Bio, Inc.
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | Q2 2026 | 2.69 | -2.51 | -439.19% | $0 | ❌ Miss | -1.70% | -9.18% | -36.82% |
Showing last 1 quarters.